Küffer, S.; Grabowski, J.; Okada, S.; Sojka, N.; Welter, S.; von Hammerstein-Equord, A.; Hinterthaner, M.; Cordes, L.; von Hahn, X.; Müller, D.;
et al. Phosphoproteomic Analysis Identifies TYRO3 as a Mediator of Sunitinib Resistance in Metastatic Thymomas. Cancers 2022, 14, 4762.
https://doi.org/10.3390/cancers14194762
AMA Style
Küffer S, Grabowski J, Okada S, Sojka N, Welter S, von Hammerstein-Equord A, Hinterthaner M, Cordes L, von Hahn X, Müller D,
et al. Phosphoproteomic Analysis Identifies TYRO3 as a Mediator of Sunitinib Resistance in Metastatic Thymomas. Cancers. 2022; 14(19):4762.
https://doi.org/10.3390/cancers14194762
Chicago/Turabian Style
Küffer, Stefan, Jessica Grabowski, Satoru Okada, Nikolai Sojka, Stefan Welter, Alexander von Hammerstein-Equord, Marc Hinterthaner, Lucia Cordes, Xenia von Hahn, Denise Müller,
and et al. 2022. "Phosphoproteomic Analysis Identifies TYRO3 as a Mediator of Sunitinib Resistance in Metastatic Thymomas" Cancers 14, no. 19: 4762.
https://doi.org/10.3390/cancers14194762
APA Style
Küffer, S., Grabowski, J., Okada, S., Sojka, N., Welter, S., von Hammerstein-Equord, A., Hinterthaner, M., Cordes, L., von Hahn, X., Müller, D., Sauer, C., Bohnenberger, H., Marx, A., & Ströbel, P.
(2022). Phosphoproteomic Analysis Identifies TYRO3 as a Mediator of Sunitinib Resistance in Metastatic Thymomas. Cancers, 14(19), 4762.
https://doi.org/10.3390/cancers14194762